Skip to main content

BioVentureHub Buzz

By Jamie Smith - 30 Jun 2017
Here's the latest buzz from the hub...

Happy Friday! Here’s the latest buzz from the AZ BioVentureHub…

 

Athera completes multiple dosing trial with its fully human antibody PC-mAb

Read more…

 

Cereno Scientific receives grants for development of CS1

Read more…

 

Corline has signed a letter of intent with Oxford University regarding clinical studies in diabetes type 1

Read more…

 

InOrbit Therapeutics have moved in!

Read more…

 

i-Tech - Stena RoRo selects Selektope® for extensive newbuild program

Read more…

 

i-Tech - a new antifouling product containing the bio-repellent ingredient Selektope® has been launched.

Read more…

 

Mölnlycke is moving in!

Read more…

 

NanoSIMS - check out the growing list of NanoSIMS/mass spectrometry publications produced by Per and his team

Read more…

 

Tataa has launched GrandPerformance assays for expression profiling of single circulating tumor cells

Read more…

 

Vicore Pharma is growing and making strategic recruitments

Read more…

 

A BIG THANK YOU to Antaros, Athera, Corline, Promimic and Q&Q Labs for participating in the full day media visit from Göteborgs-Posten that we hosted this week.

Look out for a feature article in GP in August!

 

Have a great weekend!

BVH Team  

www.azbioventurehub.com
Twitter: @BioVentureHub